Lucian R Chirieac
Overview
Explore the profile of Lucian R Chirieac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
16585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gill R, Richards W, Heiling H, Mazzola E, Hung Y, Seethamraju R, et al.
Eur J Radiol
. 2024 May;
176:111527.
PMID: 38810438
Purpose: To assess the potential of apparent diffusion coefficient (ADC) values derived from diffusion weighted (DW) MRI preoperatively to predict the predominant histologic component among biphasic pleural mesothelioma (PM) tumors....
2.
Riely G, Wood D, Ettinger D, Aisner D, Akerley W, Bauman J, et al.
J Natl Compr Canc Netw
. 2024 May;
22(4):249-274.
PMID: 38754467
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance...
3.
Husain A, Chapel D, Attanoos R, Beasley M, Brcic L, Butnor K, et al.
Arch Pathol Lab Med
. 2024 Apr;
148(11):1251-1271.
PMID: 38586983
Context.—: Mesothelioma is an uncommon tumor that can be difficult to diagnose. Objective.—: To provide updated, practical guidelines for the pathologic diagnosis of mesothelioma. Data Sources.—: Pathologists involved in the...
4.
Stevenson J, Ettinger D, Wood D, Aisner D, Akerley W, Bauman J, et al.
J Natl Compr Canc Netw
. 2024 Mar;
22(2):72-81.
PMID: 38503043
Mesothelioma is a rare cancer that originates from the mesothelial surfaces of the pleura and other sites, and is estimated to occur in approximately 3,500 people in the United States...
5.
Hung Y, Chirieac L
Arch Pathol Lab Med
. 2024 Jan;
148(5):e77-e89.
PMID: 38190277
Context.—: Molecular testing has increasingly been utilized in the evaluation of mesothelioma. Diffuse mesothelioma comprises multiple distinct genetic subgroups. While most diffuse mesotheliomas lack oncogenic kinase mutations and instead harbor...
6.
Ettinger D, Wood D, Stevenson J, Aisner D, Akerley W, Bauman J, et al.
J Natl Compr Canc Netw
. 2023 Sep;
21(9):961-979.
PMID: 37673108
Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM)....
7.
Cheng M, Huang Y, Luong N, Lopiccolo J, Nishino M, Sholl L, et al.
JCO Precis Oncol
. 2023 Jun;
7:e2200633.
PMID: 37384867
No abstract available.
8.
Ettinger D, Wood D, Aisner D, Akerley W, Bauman J, Bharat A, et al.
J Natl Compr Canc Netw
. 2023 Apr;
21(4):340-350.
PMID: 37015337
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known...
9.
Ettinger D, Wood D, Aisner D, Akerley W, Bauman J, Bharat A, et al.
J Natl Compr Canc Netw
. 2022 May;
20(5):497-530.
PMID: 35545176
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent...
10.
Naso J, Levine A, Farahani H, Chirieac L, Dacic S, Wright J, et al.
Mod Pathol
. 2021 Jun;
34(11):2028-2035.
PMID: 34112957
Sarcomatoid mesothelioma is an aggressive malignancy that can be challenging to distinguish from benign spindle cell mesothelial proliferations based on biopsy, and this distinction is crucial to patient treatment and...